Os Therapies Incorporated reports a Return on Equity (ROE) of 325.88%.

What is OSTX's dividend yield?

Os Therapies Incorporated offers a dividend yield of 0.00%.

What is OSTX's Quality Score?

Our AI rates OSTX's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy OSTX?

Our AI Timing Score for OSTX is 28 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does OSTX belong to?

Os Therapies Incorporated is classified under the Healthcare >> Biotechnology sector on the NYSE MKT exchange

Os Therapies Incorporated (OSTX) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-03-31)

OSTX AI Analysis Summary

Our AI summary for OSTX: Os Therapies Incorporated (NYSE MKT), Healthcare >> Biotechnology sector. The stock currently trades at ROE of 325.88%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 28/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

OSTX

Os Therapies Incorporated

US:NYSE MKT STOCK Healthcare >> Biotechnology News 91

USD 1.63

0.08 (5.16%) Day Change

Watchlist Portfolio Compare Chart

-0.12

D/E

325.9%

ROE

-483.3%

ROA

0.00%

Div Yield

OS THERAPIES INCORPORATED
TYPE: STOCK
MARKET: NYSE MKT

Compare Watchlist Myport

USD 1.63 Price 0.08 (5.16%) Day Change	NEWS SCORE: 91

OSTX, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

42%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	91
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	1.63
PBV / Sector	-6.52 / 44,022.72
Earning Per Share	-0.81

PE / Sector	N/A / 19.17
PEG or PE/Growth / Sector	N/A / 1.24
Average 1M Daily Value	0.75 M GREAT
Average 1W Daily Value	0.43 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 98.24
NPM Average (%) / Sector	N/A / -1,697.63
NPM Change Average (%) / Sector	N/A / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-483.25 / 185,260.96
ROA Average (%) / Sector	-653.78 / 36,684.70
ROA Change Average (%) / Sector	18.24 / 422,221.66 GOOD
ROE (%) / Sector	325.88 / 243,762.23 GREAT
ROE Average (%) / Sector	-45.80 / 48,758.47
ROE Change Average (%) / Sector	-914.25 / 424,968.10
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

Registration Details

Analyze Date	2026-08-05 08:00:39
Symbol	OSTX
Name	OS THERAPIES INCORPORATED
Sector	Healthcare >> Biotechnology
Market	NYSE MKT
Listed Shares	45.54 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	70.58 / 9,586.08

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 115 Pullman Crossing Road, Grasonville, MD, United States, 21638

Phone: 410 297 7793

Website: https://ostherapies.com

Sector: Healthcare >> Biotechnology

Description: OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.